BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19602024)

  • 1. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations.
    Ricci RP; Morichelli L; Gargaro A; Laudadio MT; Santini M
    J Cardiovasc Electrophysiol; 2009 Nov; 20(11):1244-51. PubMed ID: 19602024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote monitoring of patients with an implanted device and patients' outcomes: the potential for "win-win" dynamics.
    Boriani G; Diemberger I; Mantovani V; Biffi M; Martignani C
    J Cardiovasc Electrophysiol; 2009 Nov; 20(11):1252-4. PubMed ID: 19682165
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
    Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease management: atrial fibrillation and home monitoring.
    Ricci RP
    Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation.
    Ricci RP; Morichelli L; Santini M
    Europace; 2009 Jan; 11(1):54-61. PubMed ID: 19011260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices.
    Lorenzoni G; Folino F; Soriani N; Iliceto S; Gregori D
    J Eval Clin Pract; 2014 Oct; 20(5):570-7. PubMed ID: 24766368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly detected atrial fibrillation following dual chamber pacemaker implantation.
    Cheung JW; Keating RJ; Stein KM; Markowitz SM; Iwai S; Shah BK; Lerman BB; Mittal S
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1323-8. PubMed ID: 17081212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
    Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Ezekowitz MD; Hilker C; Miller C; Qi D; Ziegler PD
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):474-80. PubMed ID: 19843914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
    Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring in the management of atrial fibrillation.
    Lewalter T; Morgan J; Halimi F; Lip G; Dagres N; Blomström-Lundqvist C;
    Europace; 2012 Apr; 14(4):591-2. PubMed ID: 22454456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.